You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nilotinib

Showing 26 - 50 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Nilotinib
  • Los Angeles, California
  • +10 more
Jul 26, 2021

Leukemia Trial in Italy (drug, genetic, other)

Completed
  • Leukemia
  • imatinib mesylate
  • +8 more
  • Rionero in Vulture, Potenza, Italy
  • +36 more
Jan 3, 2022

Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

Active, not recruiting
Has Results
  • Chronic Myeloid Leukemia
  • nilotinib
  • Los Angeles, California
  • +61 more
Mar 17, 2022

Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Nilotinib
  • Fayetteville, Arkansas
  • +22 more
Jun 29, 2021

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Nilotinib
  • Aichi, Japan
    Novartis Investigative Site
Dec 6, 2020

Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Withdrawal;Drug
  • Imatinib withdrawal
  • +2 more
  • Brno, Czechia
  • +7 more
Aug 24, 2022

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Nilotinib
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Nilotinib
  • Bordeaux, Aquitaine, France
  • +11 more
Dec 6, 2020

Chronic Phase Chronic Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blastic Phase Chronic Myeloid Leukemia Trial

Completed
  • Chronic Phase Chronic Myeloid Leukemia
  • +4 more
  • Toronto, Ontario, Canada
    Princess Margaret Hospital / University Health Network
Oct 29, 2020

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Nilotinib
  • +10 more
  • Bordeaux, France
  • +17 more
Oct 4, 2022

Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia Trial in Worldwide (nilotinib)

Completed
Has Results
  • Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
  • nilotinib
  • Loma Linda, California
  • +35 more
Mar 25, 2021

Chronic Myelogenous Leukemia Trial in Turkey (Nilotinib)

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Nilotinib
  • Eskisehir, Meselik, Turkey
  • +12 more
Aug 18, 2020

Untreated Adult Acute Myeloid Leukemia Trial in Scottsdale, Rochester (Cytarabine, Daunorubicin Hydrochloride, Laboratory

Completed
Has Results
  • Untreated Adult Acute Myeloid Leukemia
  • Scottsdale, Arizona
  • +1 more
Aug 4, 2020

(PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK

Completed
  • Gastrointestinal Stromal Tumors
  • Nilotinib
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral Trial in Canada, United States (Nilotinib)

Completed
  • Bone Marrow Transplant Failure
  • +2 more
  • Nilotinib
  • Stanford, California
  • +4 more
Apr 13, 2020

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease Trial in United States (drug, other,

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Minimal Residual Disease
  • Goodyear, Arizona
  • +237 more
Jan 3, 2023

Leukemia Trial in Houston (MEK-162, Nilotinib, Questionnaires)

Terminated
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 10, 2020

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Glioma Trial in La Jolla (nilotinib)

Completed
Has Results
  • Glioma
  • nilotinib
  • La Jolla, California
    The Rebecca and John Moores UCSD Cancer Center
Apr 27, 2020

Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Birmingham, Alabama
  • +25 more
Mar 4, 2022

Philadelphia Positive (Ph+) Chronic Myeloid Leukemia Trial in Moscow (Nilotinib)

Terminated
Has Results
  • Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
  • Nilotinib
  • Moscow, Russian Federation
    Novartis Investigative Site
Dec 9, 2019

Leukemia, Myelogenous, Chronic Trial in Houston (Nilotinib)

Completed
Has Results
  • Leukemia, Myelogenous, Chronic
  • Nilotinib
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 16, 2019

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Longmont, Colorado
  • +128 more
Aug 1, 2022